2024-04-19  9:59:57 PM Chg. -19.06 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
726.02USD -2.56% 89,235
Turnover: 65.32 mill.
-Bid Size: - -Ask Size: - 690.11 bill.USD 0.65% 124.80

Business description

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
 

Management board & Supervisory board

CEO
David A. Ricks
Management board
Anat Ashkenazi, Eric Dozier, Anat Hakim, Edgardo Hernandez, Patrik Jonsson, Michael B. Mason, Johna L. Norton, Leigh Ann Pusey, Diogo Rau, Daniel M. Skovronsky, Jacob Van Naarden, Alonzo Weems, Anne E. White, Ilya Yuffa
Supervisory board
David A. Ricks, Ralph Alvarez, Katherine Baicker, J. Erik Fyrwald, Mary Lynne Hedley, Jamere Jackson, Kimberly H. Johnson, William G. Kaelin Jr., Juan R. Luciano, Marschall S. Runge, Gabrielle Sulzberger, Karen Walker
 

Company data

Name: Eli Lilly & Company
Address: Lilly Corporate Center,Indianapolis, Indiana 46285, USA
Phone: +1-317-276-2000
Fax: +1-317-277-6579
E-mail: -
Internet: www.lilly.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: 69.30%
IPO date: 1970-07-09

Investor relations

Name: Joe Fletcher
IR phone: +1-317-296-2884
IR Fax: -
IR e-mail: jfletcher@lilly.com

Company calendar

CW 18 | 2024-04-30 Interim Report 1st Quarter/3 Months
CW 32 | 2024-08-08 Interim Report 2nd Quarter/6 Months
CW 44 | 2024-10-30 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
52.47%
Lilly Endowment, Inc
 
10.80%
Vanguard Group, Inc. (The)
 
7.37%
Blackrock Inc.
 
6.91%
PNC Financial Services Group, Inc.
 
5.47%
State Street Corporation
 
3.50%
FMR, LLC
 
3.37%
Capital World Investors
 
2.91%
Primecap Management Company
 
2.67%
Others
 
4.53%